Description
Ataluren (PTC124) is a novel, orally administered drug that targets nonsense mutations. Ataluren is approved for use by the European Medicines Agency to treat Duchenne Muscular Dystrophy in patients aged 5 years and older who are able to walk.
Molecular Formula
C15H9FN2O3
Smiles
FC1=C(C2=NC(=NO2)C3=CC(C(O)=O)=CC=C3)C=CC=C1
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
H2O: < 1 mg/mL (insoluble or slightly soluble)Ethanol: < 1 mg/mL (insoluble or slightly soluble)DMSO: 40 mg/mL (140.73 mM), Sonication is recommended.